On the other hand, Y16, which also prevents the binding between RhoA and its GEF enzymes by binding between the DH and PH domains of Leukemia-associated RhoGEF (LARG), suppresses breast cancer proliferation, migration and invasion, as well as modifies the distribution of the actin cytoskeleton [150]. The gene discussed is RHOA; the disease is breast carcinoma.